ONE AIRNA

At AIRNA, we are developing potent RNA editing therapeutics to offer more hope to patients who currently have limited options. The passion, dedication, and wealth of knowledge of our team, combined with the data we have generated, makes me very confident in our approach.

Victor De Jesus
Associate Scientist

As someone whose life was transformed by medical breakthroughs, it’s a privilege to be part of a company that is pioneering RNA editing to serve patients with unmet need.

Sruthi V. Hindupur
Senior Scientist

Rodger Novak, MD

Board Chair

Arch Venture Partners

Forbion

Fast Track Initiative

ND Capital

ONO Venture Investment Inc.

Robert Altshuler, PhD

Director, Bioinformatics

Namita Bisaria, PhD

Head of Research Strategy and Operations

Peter Borsos

Research Associate

Elisangela Bressan, PhD

Senior Scientist

Josh Brumm

Forbion

Maegan Brunelle

Maegan Brunelle

Accounting Manager

Martina Buttschardt

Research Associate

Li-Hao Chang

Scientist

Aindrila Chatterjee, PhD

Senior Scientist

Charles Conover, PhD

Vice President, Program Management

Victor De Jesus

Associate Scientist

Eva-Maria Duerr, PhD

Senior Scientist

Kris Elverum

President and Chief Executive Officer

Kris Elverum

President and Chief Executive Officer, AIRNA

Juri Eyberg

Senior Scientist

Kat Feldmann

Senior Executive Assistant

Lena Fischer

Vice President, Finance & Operations

Patrick Foster, PhD

Vice President and Head of CMC

Ina Gerber

Associate Director, HR & Finance

Veronica Giachin

Research Associate

Hyun Gyung Jang, PhD

Director DMPK & Clinical Pharmacology

Matthew Hawryluk, PhD

Chief Business Officer

Sruthi V. Hindupur, PhD

Senior Scientist

Inga Jarmoskaite, PhD

Senior Scientist

Sean Kendall, MS

ARCH Venture Partners

Robin Klimek, PhD

Senior Scientist

Kaiko Kunii

In Vivo Pharmacologist

Jin Billy Li, PhD

Stanford University

Konstantin Licht, PhD

Senior Scientist

Dirk Lindenblatt, PhD

Senior Scientist

Aline Mack

Research Associate

Kristyn McCandless

Contracts Manager

Amy Mendel

Interim Chief Legal Officer

Tobias Merkle, PhD

Vice President, Platform

Daniella Mizurini, PhD

Associate Principal Scientist

Eric Moessinger

ND Capital

Negin Namazian

Senior Research Associate

Angelika Oswald, PhD

Scientist

Aakash Parikh

Lab Manager

Elena Poser, PhD

Principal Scientist

Piotr Putaj, PhD

Associate Director, Chemistry

Fernanda Sachenbacher, PhD

Senior Scientist

Lange Yakubu Saleh, PhD

Scientist

Sriram Sathy, PhD

Chief Scientific Officer

Carolin Schlitz

Research Associate

Anindya Sen, PhD

Vice President, Preclinical Development

Devyn Smith, PhD

Arbor Bio

Luise Stafforst, PhD

Lab manager

Thorsten Stafforst, PhD

University of Tübingen

Thorsten Stafforst, PhD

University of Tübingen

Stephen Su, PhD

Senior Director, Target Validation

Rewati Tappu, PhD

Senior Scientist

Colleen Tucker, MS

Head of People

Manvi Upadhyay

Senior Research Associate

Paul Vogel, PhD

Vice President, Discovery

Paul Vogel, PhD

Vice President, Discovery

Christopher Volkert

Senior Research Associate